Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL).

Vincent Grobost, Sami Hammi, Bruno Pereira,Alexandre Guilhem,Pierre Duffau,Julie Seguier,Antoine Parrot,Giovanni Gautier, Laurent Alric,Mallorie Kerjouan,Xavier Le Guillou, Delphine Simon,Laurent Chaussavoine, Murielle Rondeau-Lutz,Vanessa Leguy-Seguin,Laura Delagrange,Christian Lavigne,Hélène Maillard,Sophie Dupuis-Girod

Thrombosis research（2023）

引用 0|浏览15

暂无评分

摘要

Tolerance of AC or AP therapy was similar in HHT population but not dual AP therapy. We identified risk factors for MBE occurrence or premature discontinuation under AT.

查看译文

关键词

Hereditary hemorrhagic telangiectasia, Anticoagulant, Antiplatelet, Direct oral anticoagulant, Major bleeding event

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要